| SCHEDULE OF REPORTABLE SEGMENT LOSS |
The
following table presents reportable segment loss, including significant expenses regularly provided to the CODM, attributable to the
Company’s reportable segment for the three and six months ended June 30, 2026 and 2025:
SCHEDULE OF REPORTABLE SEGMENT LOSS
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
For the Three Months
Ended June 30, | | |
For the Six Months Ended
June 30, | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Research and development | |
| | | |
| | | |
| | | |
| | |
| External research and development | |
$ | 317,979 | | |
$ | 1,687,877 | | |
$ | 677,169 | | |
$ | 4,003,989 | |
| Internal personnel costs | |
| 45,148 | | |
| 479,237 | | |
| 177,092 | | |
| 973,965 | |
| Total research and development | |
| 363,127 | | |
| 2,167,114 | | |
| 854,261 | | |
| 4,977,954 | |
| General and administrative | |
| 1,445,739 | | |
| 2,289,649 | | |
| 3,114,193 | | |
| 4,051,368 | |
| | |
| | | |
| | | |
| | | |
| | |
| Total operating expenses | |
| 1,808,866 | | |
| 4,456,763 | | |
| 3,968,454 | | |
| 9,029,322 | |
| | |
| | | |
| | | |
| | | |
| | |
| Other income (expense) | |
| | | |
| | | |
| | | |
| | |
| Warrant repricing | |
| - | | |
| - | | |
| (410,154 | ) | |
| - | |
| Change in fair value of convertible promissory notes | |
| - | | |
| (787,703 | ) | |
| - | | |
| (787,703 | ) |
| Other income, net | |
| 14,003 | | |
| 15,547 | | |
| 42,675 | | |
| 55,676 | |
| | |
| | | |
| | | |
| | | |
| | |
| Total other income (expense) | |
| 14,003 | | |
| (772,156 | ) | |
| (367,479 | ) | |
| (732,027 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
$ | (1,794,863 | ) | |
$ | (5,228,919 | ) | |
$ | (4,335,933 | ) | |
$ | (9,761,349 | ) |
|